Industry News
Pharmaceutical Industry News
If You’re Retired, or Not: 5 Changes That Will Affect Your Money in 2025
This year, older workers will have ways to save more for retirement, spend less on medicine and see other ways to improve their finances.
RFK Jr. Sought to Stop Covid Vaccinations 6 Months After Rollout
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and considered life-saving.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.
FDA Bans Red Dye 3 in Foods, Linking It to Cancer in Rats
Consumer and food safety groups have long urged the agency to revoke the use of this dye and others. The F.D.A. says studies have shown that it causes cancer in rats, but not in humans.
Ramaswamy Has a High-Profile Perch and a Raft of Potential Conflicts
Vivek Ramaswamy, Elon Musk’s partner in an effort to cut government costs, could make decisions that ultimately make him and his investors richer.
How a Company Makes Millions Off a Hospital Program Meant to Help the Poor
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
¿Las cremas con estrógeno sirven para mejorar la piel?
Algunas empresas de cosméticos están comercializando cremas y sueros faciales con estrógenos para personas menopáusicas. Esto dice la evidencia.
Scientists May Be Able to Make Grapefruits Compatible With Medications They Currently Interfere With
Scientists have identified a gene that causes production of a substance in some citrus that interferes with many medications.
Health Tips for International Travel: What to Know About Insurance and Medicine
What medications should you bring, what insurance do you need and how do you find a doctor? Here are health care tips if you’re traveling internationally.
Patti Davis’s Reflections on Joe Biden and Her Dad, Ronald Reagan
Readers discuss a guest essay about the aging of two presidents. Also: A peaceful Jan. 6; the Palestinians’ future; mind-altering drugs.
In Africa, Danger Slithers Through Homes and Fields
Venomous snakes bite millions of people worldwide each year, killing at least 120,000. Many of them are poor people in rural areas of Africa without easy access to treatment.
Drug Company to Share Revenues With Indigenous People Who Donated Their Genes
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.
Can Estrogen Cream Reverse Skin Aging?
Some cosmetics companies are marketing estrogen-infused face creams and serums to people in menopause. Do they work?
Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report
But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.
Should TV Ads for Drugs Be Banned?
Readers discuss a proposal by some Trump allies. Also: The abuses inside prisons; stories of miracles.
In France, Drug Traffic Spreads to Small Towns
Even quaint corners of the country are seeing a rise in drug violence and crime. Just ask the mayor of Morlaix, which has a population of about 15,000.
Partisan Judges and Public Disrespect
Readers discuss the plummeting respect for the judicial system. Also: Syria sanctions; religion and Democrats; medical uses of psychedelics.
Jimmy Carter’s Quiet but Monumental Work in Global Health
In his decades as a former president, he and his wife, Rosalynn Carter, helped bring lifesaving treatments and sanitation to poor people around the world.
Pfizer Stopped Us From Getting Ozempic Decades Ago
Researchers identified one key breakthrough for GLP-1 drugs in the 1980s, but Pfizer walked away.